GC
SUPN icon

Globeflex Capital’s Supernus Pharmaceuticals SUPN Stock Holding History

Globeflex Capital’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25,563
Closed -$643K – 488
2020
Q4 		$643K Buy
25,563
+64
+0.3% +$1.38K 0.14% 244
2020
Q3 		$531K Hold
25,499
– – 0.14% 244
2020
Q2 		$606K Buy
25,499
+4,472
+21% +$98.8K 0.15% 233
2020
Q1 		$378K Hold
21,027
– – 0.12% 279
2019
Q4 		$499K Sell
21,027
-812
-4% -$19.7K 0.09% 317
2019
Q3 		$600K Sell
21,839
-4,700
-18% -$139K 0.13% 259
2019
Q2 		$878K Sell
26,539
-22
-0.1% -$754 0.18% 186
2019
Q1 		$931K Sell
26,561
-658
-2% -$24.5K 0.2% 177
2018
Q4 		$904K Sell
27,219
-7,742
-22% -$333K 0.22% 155
2018
Q3 		$1.76M Sell
34,961
-400
-1% -$19.8K 0.35% 85
2018
Q2 		$2.12M Sell
35,361
-2,800
-7% -$145K 0.43% 51
2018
Q1 		$1.75M Buy
38,161
+19,100
+100% +$797K 0.37% 76
2017
Q4 		$760K Hold
19,061
– – 0.21% 180
2017
Q3 		$762K Buy
19,061
+5,700
+43% +$247K 0.22% 172
2017
Q2 		$576K Hold
13,361
– – 0.14% 227
2017
Q1 		$418K Hold
13,361
– – 0.1% 294
2016
Q4 		$337K Buy
+13,361
New +$299K 0.08% 306
2016
Q1 		– Sell
-17,278
Closed -$232K – 493
2015
Q4 		$232K Hold
17,278
– – 0.06% 302
2015
Q3 		$242K Sell
17,278
-84,300
-83% -$1.57M 0.05% 362
2015
Q2 		$1.73M Buy
101,578
+101,514
+158,616% +$1.44M 0.32% 82
2015
Q1 		$1K Sell
64
-30
-32% -$283 ﹤0.01% 468
2014
Q4 		$1K Sell
94
-16
-15% -$134 ﹤0.01% 466
2014
Q3 		$1K Buy
+110
New +$994 ﹤0.01% 484

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Globeflex Capital's SUPN Position: Q1 2021 in Review

Globeflex Capital sold out of Supernus Pharmaceuticals (SUPN) in Q1 2021, closing a stake of 25,563 shares — an estimated $643K sold.

Globeflex Capital first reported a position in SUPN in Q3 2014 and held it in 23 quarters. The position peaked at $2.12M in Q2 2018. 224 funds tracked by Wall St. Rank hold SUPN as of Q1 2021.

  • Globeflex Capital reported no remaining Supernus Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Globeflex Capital sold 25,563 Supernus Pharmaceuticals shares in Q1 2021, an estimated $643K.
  • Globeflex Capital first reported a position in Supernus Pharmaceuticals in Q3 2014 and held it in 23 quarters.
  • Globeflex Capital's Supernus Pharmaceuticals position peaked at $2.12M in Q2 2018.
  • 224 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2021.

Based on Globeflex Capital's 13F filing for Q1 2021, filed 14 May 2021.